Longboard Pharmaceuticals, Inc. (LBPH) Misses Q3 EPS by 2c

Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q3 EPS of ($0.68), $0.02 worse than the analyst estimate of ($0.66).

For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c